Jack Penney

Massachusetts General Hospital, Boston, MA 
basal ganglia, Parkinson's disease, Huntington's disease
"Jack Penney"
Mean distance: 15.51 (cluster 32)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Biglan KM, Shoulson I, et al. (2015) Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9
Brocklebank D, Gayán J, Andresen JM, et al. (2009) Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implications. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 425-9
Deng YP, Albin RL, Penney JB, et al. (2004) Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. Journal of Chemical Neuroanatomy. 27: 143-64
Wexler NS, Lorimer J, Porter J, et al. (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America. 101: 3498-503
Spektor BS, Miller DW, Hollingsworth ZR, et al. (2002) Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease. Brain Research. Molecular Brain Research. 102: 118-28
Shoulson I, Penney J, McDermott M, et al. (2001) A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology. 56: 455-62
Cha JH, Farrell LA, Ahmed SF, et al. (2001) Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein. Neurobiology of Disease. 8: 90-102
Orlando LR, Alsdorf SA, Penney JB, et al. (2001) The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Experimental Neurology. 167: 196-204
Augood SJ, Hollingsworth ZR, Standaert DG, et al. (2000) Localization of dopaminergic markers in the human subthalamic nucleus. The Journal of Comparative Neurology. 421: 247-55
Küppenbender KD, Standaert DG, Feuerstein TJ, et al. (2000) Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. The Journal of Comparative Neurology. 419: 407-21
See more...